ACC 2024

Heart Failure and Cardiomyopathy

Acute Coronary Syndrome and Acute Myocardial Infarction

Interventional Cardiology in 2024

Self-expanding versus balloon-expendable TAVR in patients with small aortic annuli

Presented By

Prof. Howard Herrmann, Perelman School of Medicine, PA, USA

Trial

SMART

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:52

Safety of TAVI non-inferior to SAVR for patients with lower surgical risk

Presented By

Prof. Moritz Seiffert, BG University Hospital Bergmannsheil, Germany

Trial

DEDICATE-DZHK6

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:50

Interatrial shunt for HF: neutral primary endpoint but potential benefit in HFrEF

Presented By

Prof. Gregg Stone, Icahn School of Medicine at Mount Sinai, NY, USA

Trial

RELIEVE-HF

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:45

Peripheral artery disease: procedure-guidance by IVUS superior to angiography

Presented By

Prof. Young-Guk Ko, Severance Cardiovascular Hospital; Yonsei University, South Korea

Trial

IVUS-DCB

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:43

IVUS-guided PCI beats angiography in patients with acute coronary syndrome

Presented By

Prof. Shao-Liang Chen, Nanjing Medical University, China

Trial

IVUS-ACS

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:40

Addressing frailty in patients undergoing TAVR

Presented By

Dr Jonathan Afilalo, McGill University, Canada

Trial

PERFORM-TAVR

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:36

Novel Developments in Risk Factor Management

Preventive PCI of vulnerable intracoronary plaque leads to favourable outcomes

Presented By

Prof. Seung-Jung Park, University of Ulsan College of Medicine, South Korea

Trial

PREVENT

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 14:52

KARDIA-2: Add-on zilebesiran effectively lowers blood pressure

Presented By

Dr Akshay Desai, Brigham and Women's Hospital, USA

Trial

Phase 2, KARDIA-2

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 14:48

BRIDGE-TIMI 73a: Olezarsen halves triglyceride levels

Presented By

Dr Brian Bergmark, Brigham and Women's Hospital, USA

Trial

Phase 2, BRIDGE-TIMI 73a

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 14:41

Plozasiran: A novel approach to severe hypertriglyceridaemia

Presented By

Prof. Daniel Gaudet, University of Montreal, Canada

Trial

Phase 2, SHASTA-2

Conference

ACC 2024

16 May 2024 14:22

High-risk and very high-risk patients meet LDL-cholesterol targets with lerodalcibep

Presented By

Prof. Eric Klug, University of the Witwatersrand, South Africa

Trial

Phase 3, LIBerate-HR

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 14:15

No cardioprotective effect of ACE inhibitors in patients with cancer

Presented By

Dr David Austin, South Tees Hospitals, UK

Trial

Phase 3, PROACT

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 14:06

Best of Posters

Meet the Trialists

Meet the Trialist: The “Sweet Spot” from RELIEVE-HF

Expert

Prof.Gregg Stone

Trial

RELIEVE-HF

Conference

ACC 2024

15 May 2024 15:40

Meet the Trialist: The EMPACT-MI trial findings

Expert

Prof. Javed Butler

Trial

Phase 3, EMPACT-MI

Conference

ACC 2024

15 May 2024 15:33